Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study

• DOI: 10.1126/sciimmunol.abf3733
• Publication Date: 2021-08-10T15:41:51Z
• Authors: Nadine Rouphael; Holden Maecker; Ruth R. Montgomery; Joann Diray-Arce; Steven H. Kleinstein; Matthew C. Altman; Steven E. Bosinger; Walter Eckalbar; Leying Guan; Catherine L. Hough; Florian Krammer; Charles Langelier; Ofer Levy; Kerry McEnaney; Bjoern Peters; Adeeb Rahman; Jayant V. Rajan; Steven Sigelman; Hanno Steen; Harm van Bakel; Alyssa Ward; Michael R. Wilson; Prescott Woodruff; Colin R. Zamecnik; Alison D. Augustine; Al Ozonoff; Elaine F. Reed; Patrice M. Becker; Nelson Agudelo Hi...; Matthew C. Altman; Mark A. Atkinson; Lindsey R. Baden; Patrice M. Becker; Christian Bime; Scott C. Brakenridge; Carolyn S. Calfee; Charles B. Cairns; David Corry; Mark M. Davis; Alison D. Augustine; Lauren I. R. Ehrlich; Elias K. Haddad; David J. Erle; Ana Fernandez-Sesma; David A. Hafler; Catherine L. Hough; Farrah Kheradmand; Steven H. Kleinstein; Monica Kraft; Ofer Levy; Grace A. McComsey; Esther Melamed; William Messer; Jordan Metcalf; Ruth R. Montgomery; Kari C. Nadeau; Al Ozonoff; Bjoern Peters; Bali Pulendran; Elaine F. Reed; Nadine Rouphael; Minnie Sarwal; Joanna Schaenman; Rafick Sekaly; Albert C. Shaw; Viviana Simon
• Keywords: Data Analysis; Proteomics; 0301 basic medicine; Coronaviruses; Clinical Sciences; Immunology; 610; Clinical sciences; Immunophenotyping; 03 medical and health sciences; Coronaviruses Therapeutics and Interventions; Clinical Research; Research Resources; 616; Humans; Minority Health; IMPACC Network Steering Committee; Longitudinal Studies; Prospective Studies; Biomedical and Clinical Sciences; SARS-CoV-2; Gene Expression Profiling; COVID-19; Computational Biology; United States; 4.1 Discovery and preclinical testing of markers and technologies; 3. Good health; Hospitalization; Infectious Diseases; Emerging Infectious Diseases; Molecular Diagnostic Techniques; IMPACC Manuscript Writing Team; Biomarkers; 2.4 Surveillance and distribution; 4.2 Evaluation of markers and technologies

IMPACC is a multicenter longitudinal study assessing clinical and immunologic manifestations of COVID-19 in hospitalized patients.